Literature DB >> 12718888

The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling.

Dimitar Angelov1, Annie Molla, Pierre-Yves Perche, Fabienne Hans, Jacques Côté, Saadi Khochbin, Philippe Bouvet, Stefan Dimitrov.   

Abstract

The unusual histone variant macroH2A (mH2A) has been associated with repression of transcription, but the molecular mechanisms by which it exerts this function are unknown. Here we have identified a mechanism by which the different domains of mH2A may be involved in the repression of transcription. Evidence is presented that the presence of mH2A in a positioned nucleosome interferes with the binding of the transcription factor NF-kappaB. The nonhistone region of mH2A was identified to be associated with this interference. Importantly, the presence of macroH2A was found to severely impede SWI/SNF nucleosome remodeling and movement to neighboring DNA segments. This property of mH2A was demonstrated to reside only in its H2A-like domain. A hypothesis explaining the role of histone variants in transcriptional regulation is proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718888     DOI: 10.1016/s1097-2765(03)00100-x

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  97 in total

1.  Histone variant H2ABbd confers lower stability to the nucleosome.

Authors:  Thierry Gautier; D Wade Abbott; Annie Molla; Andre Verdel; Juan Ausio; Stefan Dimitrov
Journal:  EMBO Rep       Date:  2004-06-11       Impact factor: 8.807

2.  SWI/SNF remodeling and p300-dependent transcription of histone variant H2ABbd nucleosomal arrays.

Authors:  Dimitar Angelov; André Verdel; Woojin An; Vladimir Bondarenko; Fabienne Hans; Cécile-Marie Doyen; Vassily M Studitsky; Ali Hamiche; Robert G Roeder; Philippe Bouvet; Stefan Dimitrov
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

3.  Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase.

Authors:  Wanil Kim; Goutam Chakraborty; Sangjune Kim; Joon Shin; Choon-Ho Park; Min-Woo Jeong; Nagakumar Bharatham; Ho Sup Yoon; Kyong-Tai Kim
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

4.  ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression.

Authors:  Kajan Ratnakumar; Luis F Duarte; Gary LeRoy; Dan Hasson; Daniel Smeets; Chiara Vardabasso; Clemens Bönisch; Tianying Zeng; Bin Xiang; David Y Zhang; Haitao Li; Xiaowo Wang; Sandra B Hake; Lothar Schermelleh; Benjamin A Garcia; Emily Bernstein
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

Review 5.  Histone variants in metazoan development.

Authors:  Laura A Banaszynski; C David Allis; Peter W Lewis
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

Review 6.  New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?

Authors:  Karolin Luger; Mekonnen L Dechassa; David J Tremethick
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-22       Impact factor: 94.444

Review 7.  Histone structure and nucleosome stability.

Authors:  Leonardo Mariño-Ramírez; Maricel G Kann; Benjamin A Shoemaker; David Landsman
Journal:  Expert Rev Proteomics       Date:  2005-10       Impact factor: 3.940

8.  Structural characterization of the histone variant macroH2A.

Authors:  Srinivas Chakravarthy; Sampath Kumar Y Gundimella; Cecile Caron; Pierre-Yves Perche; John R Pehrson; Saadi Khochbin; Karolin Luger
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 9.  The end adjusts the means: heterochromatin remodelling during terminal cell differentiation.

Authors:  Sergei A Grigoryev; Yaroslava A Bulynko; Evgenya Y Popova
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

10.  Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome.

Authors:  Brian P Chadwick; Huntington F Willard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.